Acadian Asset Management’s Enliven Therapeutics ELVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,825
Closed -$46K 1776
2024
Q3
$46K Buy
+1,825
New +$46K ﹤0.01% 1810
2022
Q1
Sell
-2,148
Closed -$19K 1677
2021
Q4
$19K Buy
+2,148
New +$19K ﹤0.01% 1613